0
0

Department of Health and Human Services Awarded a Contract to RESEARCH TRIANGLE INSTITUTE for $17,722,619.00

Signed on

6/7/2022, 12:00 AM

RESEARCH TRIANGLE INSTITUTE Government Contract #75N95022D00016

RESEARCH TRIANGLE INSTITUTE was awarded a contract with the United States Government for $17,722,619.00. The contract was awarded by the agency office NATIONAL INSTITUTES OF HEALTH NIDA, which is a division with the National Institutes of Health within the Department of Health and Human Services.

Summary of Award

The recipient of the federal contract is Research Triangle Institute, a U.S.-owned nonprofit organization based in North Carolina. The contract, funded by the Department of Health and Human Services through the National Institutes of Health, is for the synthesis and distribution of drugs of abuse and related compounds. The contract is valued at $14,004,330, with a minimum amount of $10,000. There are no notable spending patterns or transactions listed in the provided data.

Contract Details

Contract ID75N95022D00016
Contract TypeIDV_B_B
Total Obligation$0.00
Exercised Options
Base Amount + Options$17,722,619.00
Date Signed2022-06-07
Contract DescriptionSYNTHESIS AND DISTRIBUTION OF DRUGS OF ABUSE AND RELATED COMPOUNDS. POP: JUNE 9, 2022 - JUNE 8, 2023. CONTRACT TYPE: IDIQ - TASK ORDER CONTRACT AMOUNT NOT-TO-EXCEED: $14,004,330 POP: 06/09/2022 - 06/08/2027 CONTRACT MINIMUM: $10,000
Start Date2022-06-09
End Date2027-06-08

Agency Details

Awarding AgencyDepartment of Health and Human Services
Awarding Sub AgencyNational Institutes of Health
Awarding OfficeNATIONAL INSTITUTES OF HEALTH NIDA
Funding AgencyDepartment of Health and Human Services
Funding Sub AgencyNational Institutes of Health
Funding OfficeNATIONAL INSTITUTES OF HEALTH NIDA

Recipient Details

RecipientRESEARCH TRIANGLE INSTITUTE
Recipient Location3040 E CORNWALLIS RD RESEARCH TRIANGLE PARK NORTH CAROLINA, UNITED STATES
Business CategoriesCategory Business, Corporate Entity Tax Exempt, Nonprofit Organization, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Comments

Award Transactions